| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.094 | 0.06 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.088 | 0.07 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.077 | 0.08 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.075 | 0.1 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | -0.06 | 0.2 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.059 | 0.2 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.056 | 0.3 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.052 | 0.3 |